A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Bayer Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Many patients with ER-positive/HER2-negative advanced breast cancer eventually develop resistance to standard first-line ...